ANG Lifesciences India Limited (BOM:540694)

ANG Lifesciences India Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	35.79	1.57	3.19	3.24	3.46	38.63
Short-Term Investments	-	34.78	54.17	58.53	63.06	-
Cash & Short-Term Investments	35.79	36.36	57.35	61.78	66.52	38.63
Cash Growth	-9.62%	-36.61%	-7.16%	-7.14%	72.20%	7.29%
Accounts Receivable	871.09	665.39	732.78	831.48	1,021	587.43
Other Receivables	-	9.91	8.08	15.19	10.82	54.71
Receivables	871.09	675.29	740.85	846.67	1,031	642.15
Inventory	506.06	541.09	477.66	484.87	369.59	192.59
Prepaid Expenses	-	1.47	2.09	3.43	3.04	1
Other Current Assets	401.45	399.19	511.41	451.78	457.61	284.33
Total Current Assets	1,814	1,653	1,789	1,849	1,928	1,159
Property, Plant & Equipment	537.85	571.93	583.97	881.48	926.14	238.65
Long-Term Investments	0.26	0.26	0.26	0.26	0.26	35.2
Other Intangible Assets	-	-	-	-	-	2.31
Long-Term Deferred Tax Assets	73.44	63.72	44.59	41.2	42.85	-
Other Long-Term Assets	6.71	6.64	6.19	5.16	12.93	1.66
Total Assets	2,433	2,296	2,424	2,777	2,910	1,437
Accounts Payable	753.35	660.74	661.79	681.86	706.29	400.4
Accrued Expenses	1.75	105.45	98.47	62.56	59.61	77.84
Short-Term Debt	-	558.83	503.25	449.29	465.84	329.39
Current Portion of Long-Term Debt	773.57	56.89	49.7	45.16	87.74	31.93
Current Portion of Leases	9.5	9.04	8.18	5.04	-	-
Current Income Taxes Payable	0.68	0.76	42.63	176.63	189.11	50.47
Current Unearned Revenue	-	12	10	-	-	-
Other Current Liabilities	172.23	30.66	71.64	202.31	154.3	25.59
Total Current Liabilities	1,711	1,434	1,446	1,623	1,663	915.61
Long-Term Debt	101.84	188.61	139.49	184.94	216.37	70.29
Long-Term Leases	13.83	18.7	27.73	23.06	-	-
Pension & Post-Retirement Benefits	14.57	12.76	11.44	10.61	14.95	4.53
Long-Term Deferred Tax Liabilities	-	-	13.34	14.91	6.15	2.39
Other Long-Term Liabilities	1.25	1.75	23.94	58.08	172.25	27.86
Total Liabilities	1,843	1,656	1,662	1,914	2,073	1,021
Common Stock	130.58	130.58	130.58	130.58	103.67	51.83
Additional Paid-In Capital	-	56.17	56.17	56.17	63.09	105.06
Retained Earnings	-	406.09	529.11	628.51	624.02	258.94
Comprehensive Income & Other	459.49	46.91	46.91	46.91	46.91	-
Shareholders' Equity	590.08	639.76	762.77	862.18	837.69	415.83
Total Liabilities & Equity	2,433	2,296	2,424	2,777	2,910	1,437
Total Debt	898.74	832.06	728.37	707.48	769.95	431.61
Net Cash (Debt)	-862.95	-795.7	-671.01	-645.71	-703.43	-392.98
Net Cash Per Share	-66.42	-60.93	-51.39	-49.70	-54.28	-30.33
Filing Date Shares Outstanding	13.16	13.06	13.06	13.06	12.96	12.96
Total Common Shares Outstanding	13.16	13.06	13.06	13.06	12.96	12.96
Working Capital	103.31	219.03	343.7	225.69	265.23	243.08
Book Value Per Share	44.85	48.99	58.41	66.03	64.65	32.09
Tangible Book Value	590.08	639.76	762.77	862.18	837.69	413.52
Tangible Book Value Per Share	44.85	48.99	58.41	66.03	64.65	31.91
Land	-	60.1	57.78	148.57	153.43	23.81
Buildings	-	445.69	409.6	515.7	519.71	130.83
Machinery	-	710.32	693.16	774.45	746.59	218.87
Construction In Progress	-	-	-	-	-	4.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.